FY2026 Earnings Forecast for Plexus Issued By Zacks Research

Plexus Corp. (NASDAQ:PLXS) – Investment analysts at Zacks Research boosted their FY2026 earnings estimates for Plexus in a research note issued on Thursday, May 21st. Zacks Research analyst Team now anticipates that the technology company will post earnings per share of $5.87 for the year, up from their prior estimate of $5.86. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Plexus’ current full-year earnings is $5.98 per share. Zacks Research also issued estimates for Plexus’ Q1 2027 earnings at $1.51 EPS, Q2 2027 earnings at $1.62 EPS, Q3 2027 earnings at $1.49 EPS, Q4 2027 earnings at $1.94 EPS, FY2027 earnings at $6.55 EPS, Q1 2028 earnings at $2.06 EPS, Q2 2028 earnings at $2.08 EPS and FY2028 earnings at $8.31 EPS.

Plexus (NASDAQ:PLXS) last released its earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.18. The business had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.13 billion. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The firm’s revenue for the quarter was up 18.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.66 earnings per share. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS.

A number of other research analysts also recently commented on the stock. Williams Trading set a $195.00 price objective on shares of Plexus in a research report on Wednesday, January 28th. Benchmark reissued a “buy” rating and issued a $220.00 price objective on shares of Plexus in a research report on Monday, March 16th. Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Weiss Ratings raised shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, May 11th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a research report on Thursday, April 30th. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $229.17.

Plexus Price Performance

Plexus stock opened at $265.72 on Monday. The company has a fifty day simple moving average of $230.26 and a 200 day simple moving average of $190.48. Plexus has a 1-year low of $115.35 and a 1-year high of $275.83. The company has a market cap of $7.11 billion, a P/E ratio of 38.85 and a beta of 0.88. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06.

Hedge Funds Weigh In On Plexus

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Plexus by 0.6% in the 3rd quarter. Vanguard Group Inc. now owns 3,683,845 shares of the technology company’s stock valued at $533,016,000 after buying an additional 22,374 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Plexus by 0.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,457 shares of the technology company’s stock valued at $201,903,000 after buying an additional 7,051 shares in the last quarter. American Century Companies Inc. raised its position in shares of Plexus by 44.2% in the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock valued at $159,722,000 after buying an additional 338,119 shares in the last quarter. State Street Corp grew its holdings in shares of Plexus by 2.3% during the 2nd quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock valued at $143,361,000 after purchasing an additional 24,115 shares during the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in shares of Plexus by 4.0% during the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 915,296 shares of the technology company’s stock valued at $132,434,000 after purchasing an additional 35,237 shares during the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Plexus

In other Plexus news, Director Karen Marie Rapp sold 500 shares of Plexus stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $195.59, for a total value of $97,795.00. Following the completion of the sale, the director owned 8,535 shares in the company, valued at $1,669,360.65. The trade was a 5.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of Plexus stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $271.23, for a total transaction of $813,690.00. Following the completion of the sale, the insider owned 10,457 shares of the company’s stock, valued at $2,836,252.11. This trade represents a 22.29% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 19,971 shares of company stock valued at $5,098,446 in the last 90 days. Insiders own 1.78% of the company’s stock.

Trending Headlines about Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Zacks Research raised its earnings estimates for Plexus across several future periods, including FY2026, FY2027, FY2028 and multiple quarterly forecasts. Higher EPS expectations can support the stock by signaling stronger profit growth ahead. Plexus earnings estimate updates
• Positive Sentiment: The company’s recent quarterly results were solid, with Plexus beating EPS and revenue estimates and posting 18.7% year-over-year revenue growth, which continues to reinforce a constructive growth outlook.
• Neutral Sentiment: CEO Todd Kelsey sold 1,500 shares in a pre-arranged Rule 10b5-1 plan. The sale was relatively small versus his remaining stake, but insider selling can still weigh on sentiment. SEC Form 4 filing
• Negative Sentiment: Zacks Research also reiterated a “Strong Sell” rating on Plexus, creating a bearish counterpoint to the higher earnings estimates and potentially limiting upside. Zacks downgrade

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.